(Q35008880)

5 August 2017

1 reference

title

Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy (English)

1 reference

5 August 2017

1 reference

Steven P Lee

1

1 reference

PubMed ID

12450732

5 August 2017

language of work or name

1 reference

1 December 2002

1 reference

Seminars in Cancer Biology

5 August 2017

1 reference

5 August 2017

12

1 reference

5 August 2017

463-471

1 reference

5 August 2017

6

1 reference

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

HLA class I and class II frequencies of a Hong Kong Chinese population based on bone marrow donor registry data

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Development of PCR-SSOP for the identification of HLA-A*02 subtypes and determination of HLA-A*02 frequencies within different ethnic populations

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Immunohistological characteristics of the infiltrating lymphoid cells and expression of HLA class I and II antigens in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Expression of HLA-DR antigens in nasopharyngeal carcinoma: An immunohistological analysis of the tumour cells and infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Analysis of the expression of Fas-L in nasopharyngeal carcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900089-5

7 January 2021

10.1016/S1044-579X(02)00089-5

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12450732